cancer. Blood 74: 1245-1251, 1989. 
29. Lasky LC, Bostrom B, Smith J, Moss TJ, Ramsay NKC: Clinical collection and use of 
peripheral blood stem cells in pediatric patients. Transplantation 47: 613-616, 1989. 
30. Castaigne S, Calvo F, Douay L, Thomas F, Benbunan M, Gerota J, Degos L: Successful 
haematopoietic reconstitution using autologous peripheral blood mononucleated cells in 
a patient with acute promyelocytic leukaemia. Br J Haematol 63: 209-211, 1986. 
31. Juttner CA, To LB, Haylock DN, Dyson PG, Thorp D, Dart GW, Ho JQK, Horvath N, 
Bardy P: Autologous blood stem cell transplantation. Transplant Proc 21: 2929-293 L 
1989. 
32. Juttner CA, To LB, Haylock DN, Branford A, Kimber RJ: Circulating autologous stem 
cells collected in very early remission from acute non-lymphoblastic leukaemia produce 
prompt but incomplete haemopoietic reconstitution after high dose melphalan or 
supralethal chemoradiotherapy. Br J Haematol 61: 739-745, 1985. 
33. Jones RJ, Celano P, Sharkis SJ, Sensenbrenner L: Two phases of engraftment established 
by serial bone marrow transplantation in mice. Blood 73: 397-401, 1989. 
34. Metcalf D: The granulocyte-macrophage colony-stimulating factors. Science 229: 16-22, 
1985. 
35. Andrews RG, Singer JW, Bernstein ID: Monoclonal antibody 12.8 recognizes a 115-kd 
molecule present on both unipotent and multipotent hematopoietic colony-forming cells 
and their precursors. Blood 67: 842-845, 1986. 
36. Berenson RJ, Andrews RG, Bensinger WI, Kalamasz D, Knitter G, Buckner CD, 
Bernstein ID: Antigen CD34 + marrow cells engraft lethally irradiated baboons. J Clin 
Invest 81: 951-955, 1988. 
37. Koike K, Ogawa M, Ihle JN, Miyake T, Shimizu T, Miyajima A, Yokota T, Arai K: - 
Recombinant murine granulocyte-macrophage (GM) colony-stimulating factor supports 
formation of GM and multipotential blast cell colonies in culture: comparison with the 
effects of interleukin-3. J Cell Physiol 131: 458-464, 1987. 
38. Broxmeyer HE, Williams DE, Hangoc G, Cooper C, Gillis S, Shadduck RK, Bicknell 
DC: Synergistic myelopoietic actions in vivo after administration to mice of combinations 
of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, 
and recombinant murine granulocyte/macrophage colony-stimulating factpr. Proc Natl 
Acad Sci USA 84: 3871-3875, 1987. 
39. Broxmeyer HE, Williams DE, Cooper S, Shadduck RK, Gillis S, Waheed A, Urdal DL, 
Bicknell DC: Comparative effects in vivo of recombinant murine interleukin 3, natural 
murine colony-stimulating factor-1, and recombinant murine granulocyte-macrophage 
colony-stimulating factor on myelopoiesis in mice. J Clin Invest 79: 721-730, 1987. 
40. Briddell RA, Brandt JE, Straneva JE, Leemhuis TB, Hoffman R: Regulation of a 
primitive human megakaiyocytic progenitor cell is controlled by a complex network of 
interacting cytokines. Blood 74: 231a, 1989. (abstr.) 
41. Ishibashi T, Burstein SA: Interleukin 3 promotes the differentiation of isolated single 
megakaiycytes. Blood 67: 1512-1514, 1986. 
42. Robinson BE, McGrath HE, Quesenberry PJ: Recombinant murine granulocyte 
macrophage colony-stimulating factor has megakaryocyte colony-stimulating activity and 
augments megakaryocyte colony stimulation by interleukin 3. J Clin Invest 79: 1648-1652, 
Recombinant DNA Research, Volume 16 
[337] 
